Novo Nordisk A/S Common Stock (NVO)

$89.55 0.00 (0.00%)
19:00 EST NVO Stock Quote Delayed 30 Minutes
Portfolio Grader

Exceptional Quant Score Analytics Raise Ranking of Novo Nordisk A/S (NVO) to Strong Buy

By Portfolio Grader
With a $97.2 billion market value, Novo Nordisk A/S (NYSE:NVO) ranks in the top 10% of its industry group, Pharmaceuticals, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader score places it 3 among the 133 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 33 among the 783 companies in the sector, and number 218 in the nearly 5,000 company Portfolio Grader universe.

Novo Nordisk A/S’s (NVO) Solid Quant Score Makes it a Buy

Earnings Visibility Makes Novo Nordisk A/S (NVO) a Buy

Novo Nordisk A/S’s (NVO) Stock Has Hold Recommendation Remain in Place

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap -
PE Ratio -
EPS -
Volume (Avg. Vol.) 7,301
Day's Range -
52-Week Range $77.82 - $148.15
Dividend & Yield $1.03 (1.15%)